A Novel MYH9-RET Fusion Occurrence and EGFR T790M Loss as an Acquired Resistance Mechanism to Osimertinib in a Patient with Lung Adenocarcinoma: A Case Report

Yanwei Sun,1 Lina Pei,2 Ningning Luo,3 Dongsheng Chen,3 Lingxin Meng1 1Department of Oncology, People’s Hospital of Rizhao, Rizhao, People’s Republic of China; 2Department of Pharmacy, People’s Hospital of Rizhao, Rizhao, People’s Republic of China; 3The State...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sun Y, Pei L, Luo N, Chen D, Meng L
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2020-11-01
Schriftenreihe:OncoTargets and Therapy
Schlagworte:
myh9-ret fusion
egfr exon20 p.t790m loss
lung adenocarcinoma
acquired resistance
osimertinib
Online Zugang:https://www.dovepress.com/a-novel-myh9-ret-fusion-occurrence-and-egfr-t790m-loss-as-an-acquired--peer-reviewed-article-OTT
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge